Case highlights upadacitinib and oral minoxidil improving remission in alopecia universalis and Crohn's disease, suggesting new autoimmune therapies.
This case highlights the potential of JAK is to address potentially overlapping immune-mediated disorders and suggests that upadacitinib, in combination with oral minoxidil, may promote rapid AU remission. These findings may inform future treatment approaches for complex autoimmune presentations.
No takes yet. Share an insight, caveat, or question.
Levine et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: